A cross-sectional study of functional and metabolic changes during aging through the lifespan in male mice MA Petr, I Alfaras, M Krawcyzk, WN Bair, SJ Mitchell, CH Morrell, ... Elife 10, e62952, 2021 | 60 | 2021 |
A mild increase in nutrient signaling to mTORC1 in mice leads to parenchymal damage, myeloid inflammation and shortened lifespan A Ortega-Molina, C Lebrero-Fernández, A Sanz, M Calvo-Rubio, ... Nature Aging, 1-19, 2024 | | 2024 |
A104 CRITICAL CARE: IMPROVING ICU EXERCISE, REHABILITATION, RECOVERY, AND SURVIVORSHIP: Validity And Inter-Rater Reliability Of The Swedish Simple Early Mobility (sea) Scale: A … KK Koo, T Lord, KK Huerta, K Zumwalt, S Cox, M Kho, DL Hotchkin, ... American Journal of Respiratory and Critical Care Medicine 195, 2017 | | 2017 |
Age-dependent impact of two exercise training regimens on genomic and metabolic remodeling in skeletal muscle and liver of male mice M Bernier, IN Enamorado, MC Gómez-Cabrera, M Calvo-Rubio, ... npj Aging 8 (1), 8, 2022 | 6 | 2022 |
Age‐associated vascular inflammation promotes monocytosis during atherogenesis W Du, C Wong, Y Song, H Shen, D Mori, N Rotllan, N Price, AD Dobrian, ... Aging Cell 15 (4), 766-777, 2016 | 54 | 2016 |
ANGPTL4 in metabolic and cardiovascular disease B Aryal, NL Price, Y Suarez, C Fernández-Hernando Trends in molecular medicine 25 (8), 723-734, 2019 | 161 | 2019 |
Benefits of caloric restriction in longevity and chemical-induced tumorigenesis are transmitted independent of NQO1 A Diaz-Ruiz, A Di Francesco, BA Carboneau, SR Levan, KJ Pearson, ... The Journals of Gerontology: Series A 74 (2), 155-162, 2019 | 16 | 2019 |
Caloric restriction induces heat shock response and inhibits B16F10 cell tumorigenesis both in vitro and in vivo M Garrido Novelle, A Davis, NL Price, A Ali, S Fürer Galvan, Y Zhang, ... Impact Journals, 2015 | | 2015 |
Caloric restriction induces heat shock response and inhibits B16F10 cell tumorigenesis both in vitro and in vivo MG Novelle, A Davis, NL Price, A Ali, S Fürer-Galvan, Y Zhang, K Becker, ... Aging (Albany NY) 7 (4), 233, 2015 | 8 | 2015 |
Combining a high dose of metformin with the SIRT1 activator, SRT1720, reduces life span in aged mice fed a high-fat diet DL Palliyaguru, RK Minor, SJ Mitchell, HH Palacios, JJ Licata, TM Ward, ... The Journals of Gerontology: Series A 75 (11), 2037-2041, 2020 | 17 | 2020 |
Daily caloric restriction limits tumor growth more effectively than caloric cycling regardless of dietary composition LCD Pomatto-Watson, M Bodogai, O Bosompra, J Kato, S Wong, ... Nature communications 12 (1), 6201, 2021 | 73 | 2021 |
Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging AP Gomes, NL Price, AJY Ling, JJ Moslehi, MK Montgomery, L Rajman, ... Cell 155 (7), 1624-1638, 2013 | 1455 | 2013 |
Diet composition influences the metabolic benefits of short cycles of very low caloric intake A Diaz-Ruiz, T Rhinesmith, LCD Pomatto-Watson, NL Price, F Eshaghi, ... Nature communications 12 (1), 6463, 2021 | 20 | 2021 |
Disulfiram treatment normalizes body weight in obese mice M Bernier, SJ Mitchell, D Wahl, A Diaz, A Singh, W Seo, M Wang, A Ali, ... Cell metabolism 32 (2), 203-214. e4, 2020 | 58 | 2020 |
Elucidating the mechanisms by which disulfiram protects against obesity and metabolic syndrome M Bernier, D Harney, YC Koay, A Diaz, A Singh, D Wahl, T Pulpitel, A Ali, ... npj Aging and Mechanisms of Disease 6 (1), 8, 2020 | 13 | 2020 |
Empirical versus theoretical power and type I error (false-positive) rates estimated from real murine aging research data I Alfaras, K Ejima, CVL Teixeira, C Di Germanio, SJ Mitchell, S Hamilton, ... Cell reports 36 (7), 2021 | 6 | 2021 |
Erratum: SRT1720 improves survival and healthspan of obese mice (Scientific Reports (2011) 1 (70 RK Minor, JA Baur, AP Gomes, TM Ward, A Csiszar, EM Mercken, ... Scientific reports 3, 1131, 2013 | | 2013 |
Fasting blood glucose as a predictor of mortality: Lost in translation DL Palliyaguru, EJ Shiroma, JK Nam, E Duregon, CVL Teixeira, NL Price, ... Cell metabolism 33 (11), 2189-2200. e3, 2021 | 43 | 2021 |
Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome C Escande, V Nin, NL Price, V Capellini, AP Gomes, MT Barbosa, ... Diabetes 62 (4), 1084-1093, 2013 | 360 | 2013 |
Flavonoid Apigenin Is an Inhibitor of the NAD+ ase CD38: Implications for Cellular NAD+ Metabolism, Protein Acetylation, and Treatment of Metabolic Syndrome. Diabetes 2013; 62 … C Escande, V Nin, NL Price, V Capellini, AP Gomes, MT Barbosa, ... Diabetes 63 (4), 1428-1428, 2014 | 3 | 2014 |